70-Gene signature-guided adjuvant systemic treatment adjustments in early-stage ER+ breast cancer patients: 7-year follow-up of a prospective multicenter cohort study.
Verreck EEF, Kuijer A, van Steenhoven JEC, Volders JH, van der Velden AWG, Siesling S, Timmer-Bonte ANH, Smilde TJ, Imholz ALT, Blanken-Peeters CFJM, de Valk B, Vrijaldenhoven S, Lastdrager WB, Haringhuizen AW, Hunting JCB, Hovenga S, Nieboer P, Zuetenhorst HM, Tetteroo GWM, Smorenburg CH, van Maaren MC, van Dalen T.
Verreck EEF, et al. Among authors: volders jh.
Breast Cancer Res Treat. 2024 Sep 30. doi: 10.1007/s10549-024-07496-3. Online ahead of print.
Breast Cancer Res Treat. 2024.
PMID: 39349887